Shire Plc is a Jersey-registered, Irish-headquartered manufacturer of pharmaceuticals. Originating in and with a large operational base in the United Kingdom, its brands and products include Adderall XR, Carbatrol, Fosrenol, and the recently released Vyvanse. Shire has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on NASDAQ.
| Property | Value |
|---|
| dbpedia-owl:abstract
|
- Shire Pharmaceuticals ist ein 1986 gegründetes, britisches Pharmaunternehmen mit Stammsitz in Basingstoke, Hampshire, England. Der Umsatz betrug im Jahr 2004 ca. 1.363 Millionen US-Dollar. Zu Beginn der Firmengeschichte vertrieb Shire unter dem damaligen Firmennamen AimCane Calciumpräparate (CALCICHEW®) zur Behandlung von Osteoporose und anderen Knochenkrankheiten. Das Kerngeschäft hat sich mittlerweile auf die Entwicklung von Hormonersatztherapien sowie Therapien zur Behandlung der Alzheimerkrankheit und Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) verlagert. Durch weltweite Fusionen, Akquisitionen und Distributionen hat Shire Filialen in den USA, Kanada, Irland, Frankreich, Deutschland, Italien und Spanien.
- Shire Plc is a Jersey-registered, Irish-headquartered manufacturer of pharmaceuticals. Originating in and with a large operational base in the United Kingdom, its brands and products include Adderall XR, Carbatrol, Fosrenol, and the recently released Vyvanse. Shire has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on NASDAQ.
- Fr:Shire Pharmaceuticals Group est une entreprise britannique faisant partie de l'indice FTSE 100.
|
| dbpedia-owl:formationYear
|
- 1986-01-01 00:00:00 (xsd:date)
|
| dbpedia-owl:industry
| |
| dbpedia-owl:location
| |
| dbpedia-owl:netIncome
| |
| dbpedia-owl:operatingIncome
| |
| dbpedia-owl:revenue
| |
| dbpedia-owl:thumbnail
| |
| dbpedia-owl:wikiPageExternalLink
| |
| dbpprop:companyLogo
| |
| dbpprop:companyName
| |
| dbpprop:companyType
| |
| dbpprop:foundation
| |
| dbpprop:homepage
| |
| dbpprop:industry
| |
| dbpprop:keyPeople
|
- Angus Russell, CEO
- Matthew Emmens, Chairman
|
| dbpprop:location
|
- UK Operations: Basingstoke, England
- Corporate HQ: Dublin, Ireland
- Registered Office: St Helier, Jersey
|
| dbpprop:netIncome
| |
| dbpprop:operatingIncome
| |
| dbpprop:revenue
| |
| dbpprop:wikiPageUsesTemplate
| |
| dbpprop:wordnet_type
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Shire Plc is a Jersey-registered, Irish-headquartered manufacturer of pharmaceuticals. Originating in and with a large operational base in the United Kingdom, its brands and products include Adderall XR, Carbatrol, Fosrenol, and the recently released Vyvanse. Shire has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on NASDAQ.
- Shire Pharmaceuticals ist ein 1986 gegründetes, britisches Pharmaunternehmen mit Stammsitz in Basingstoke, Hampshire, England. Der Umsatz betrug im Jahr 2004 ca. 1.363 Millionen US-Dollar. Zu Beginn der Firmengeschichte vertrieb Shire unter dem damaligen Firmennamen AimCane Calciumpräparate (CALCICHEW®) zur Behandlung von Osteoporose und anderen Knochenkrankheiten.
- Fr:Shire Pharmaceuticals Group est une entreprise britannique faisant partie de l'indice FTSE 100.
|
| rdfs:label
|
- Shire Pharmaceuticals
- Shire plc
- Shire Pharmaceuticals Group
|
| owl:sameAs
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:name
|
- Shire Plc (formerly: Shire Pharmaceuticals Group Plc)
|
| foaf:page
| |
| is dbpedia-owl:wikiPageDisambiguates
of | |
| is dbpedia-owl:wikiPageRedirects
of | |
| is owl:sameAs
of | |
| is foaf:primaryTopic
of | |
